Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Telomerase reverse transcriptase (TERT) promoter is a critical DNA regulatory element that controls the expression of the TERT gene, the rate-limiting component of the telomerase enzyme complex. In normal somatic cells, the TERT promoter is epigenetically silenced, leading to progressive telomere shortening and eventual replicative senescence [1]. However, in approximately 90% of human cancers, the promoter is reactivated, enabling cells to maintain telomere length and achieve replicative immortality [2]. This reactivation is frequently driven by highly recurrent somatic point mutations (most notably C228T and C250T) that create de novo binding sites for ETS transcription factors [3]. Because the TERT promoter contains GC-rich sequences capable of forming G-quadruplex (G4) structures, it has become a significant therapeutic target [4]. Small molecules designed to stabilize these G4 structures can physically obstruct the transcriptional machinery, thereby suppressing telomerase activity and inducing apoptosis in cancer cells [5].
Stabilization of G-quadruplex structures within the promoter region to physically block transcription factor binding and inhibit TERT gene transcription.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomerase reverse transcriptase promoter (TERT promoter).